Restricting ‘Pay-for-Delay’ Agreements
This post discusses recent fines imposed on pharmaceutical companies for pay-for-delay agreements and examines their impact on market competition and drug pricing. It analyses regulatory measures and the…
5 articles
This post discusses recent fines imposed on pharmaceutical companies for pay-for-delay agreements and examines their impact on market competition and drug pricing. It analyses regulatory measures and the…
Pharma patent search is a complex task due to the dense patent landscape and commonality of incremental innovations. This post details a structured approach to conducting thorough pharmaceutical…
Ms. Vinita Radhakrishnan examines trade secrets and patents in the pharmaceutical sector, highlighting key IP strategies and industry trends. The analysis offers insights into current practices and future…
This article examines the strategy of generic drug companies in challenging pharmaceutical patents, focusing on Paragraph IV certifications and related litigation. It highlights trends, success rates, and the…
The EU’s revised trademark law empowers customs to seize in-transit goods, raising serious concerns for Indian generic pharmaceutical exports. This development challenges established principles of territorial trademark enforcement…